Complete financial analysis of Caplin Point Laboratories Limited (CAPLIPOINT.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Caplin Point Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Haier Smart Home Co., Ltd. (6690.HK) Income Statement Analysis – Financial Results
- EVgo, Inc. (EVGOW) Income Statement Analysis – Financial Results
- European Metals Holdings Limited (EMH.L) Income Statement Analysis – Financial Results
- AVI Limited (AVI.JO) Income Statement Analysis – Financial Results
- Grupo Elektra, S.A.B. de C.V. (ELEKTRA.MX) Income Statement Analysis – Financial Results
Caplin Point Laboratories Limited (CAPLIPOINT.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.caplinpoint.net
About Caplin Point Laboratories Limited
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.77B | 14.67B | 12.63B | 10.48B | 8.63B | 6.49B | 5.40B | 4.02B | 3.08B | 2.52B | 1.73B | 1.27B | 1.07B | 779.21M | 607.07M | 591.19M | 618.93M |
| Cost of Revenue | 7.56B | 6.63B | 5.60B | 4.75B | 4.16B | 2.91B | 2.40B | 1.93B | 2.18B | 1.36B | 1.06B | 846.47M | 773.67M | 624.18M | 483.03M | 491.85M | 513.50M |
| Gross Profit | 9.21B | 8.04B | 7.03B | 5.73B | 4.47B | 3.58B | 3.00B | 2.08B | 903.64M | 1.16B | 668.11M | 423.81M | 298.49M | 155.03M | 124.04M | 99.33M | 105.42M |
| Gross Profit Ratio | 54.91% | 54.78% | 55.63% | 54.68% | 51.75% | 55.21% | 55.61% | 51.89% | 29.30% | 46.13% | 38.60% | 33.36% | 27.84% | 19.90% | 20.43% | 16.80% | 17.03% |
| Research & Development | 737.20M | 631.90M | 592.70M | 536.95M | 530.14M | 281.86M | 236.81M | 140.88M | 72.46M | 58.82M | 20.80M | 6.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 168.30M | 0.00 | 228.90M | 166.03M | 103.87M | 50.90M | 25.57M | 4.28M | 239.64M | 201.50M | 12.71M | 10.88M | 0.00 | 42.99M | 0.00 | 42.16M | 38.66M |
| Selling & Marketing | 284.40M | 0.00 | 275.10M | 180.32M | 28.96M | 8.99M | 40.62M | 875.00K | 537.00K | 1.47M | 14.63M | 10.23M | 0.00 | 6.73M | 0.00 | 4.34M | 4.86M |
| SG&A | 452.70M | 1.06B | 504.00M | 346.35M | 132.83M | 59.90M | 66.20M | 4.28M | 127.03M | 202.97M | 190.00M | 124.76M | 0.00 | 49.72M | 0.00 | 46.50M | 43.52M |
| Other Expenses | 0.00 | 4.07B | 2.43B | 1.91B | 1.50B | 1.76M | 712.00K | 813.82M | -5.26M | 595.95M | 313.39M | 219.86M | 201.68M | 240.00K | 79.22M | 330.00K | 3.66M |
| Operating Expenses | 2.17B | 4.07B | 3.53B | 2.80B | 2.17B | 1.49B | 1.24B | 958.98M | 204.75M | 654.77M | 334.19M | 219.86M | 201.68M | 84.91M | 79.22M | 68.99M | 93.92M |
| Cost & Expenses | 9.74B | 10.71B | 9.13B | 7.55B | 6.33B | 4.40B | 3.63B | 2.89B | 2.39B | 2.01B | 1.40B | 1.07B | 975.35M | 709.09M | 562.25M | 560.84M | 607.43M |
| Interest Income | 472.80M | 354.10M | 235.00M | 186.07M | 74.45M | 19.92M | 30.37M | 59.26M | 33.15M | 29.47M | 24.00M | 20.43M | 23.81M | 12.65M | 0.00 | 13.14M | 5.44M |
| Interest Expense | 7.80M | 7.80M | 7.00M | 15.90M | 3.20M | 600.00K | 612.00K | 1.28M | 0.00 | 2.30M | 1.23M | 3.02M | 8.22M | 10.02M | 8.34M | 9.55M | 6.68M |
| Depreciation & Amortization | 534.40M | 449.90M | 469.00M | 369.71M | 316.19M | 234.25M | 189.95M | 132.98M | 99.70M | 83.79M | 35.36M | 15.40M | 12.37M | 23.24M | 20.93M | 20.08M | 24.65M |
| EBITDA | 6.18B | 4.97B | 4.33B | 3.52B | 3.02B | 2.51B | 1.95B | 1.35B | 904.44M | 619.98M | 399.09M | 238.53M | 109.18M | 93.37M | 65.75M | 50.43M | 36.14M |
| EBITDA Ratio | 36.88% | 33.89% | 34.25% | 33.46% | 34.29% | 37.79% | 37.80% | 33.66% | 25.89% | 24.63% | 22.73% | 17.27% | 10.18% | 11.98% | 10.83% | 8.53% | 5.84% |
| Operating Income | 7.23B | 4.52B | 3.86B | 3.14B | 2.64B | 2.09B | 1.76B | 1.13B | 698.89M | 531.97M | 333.92M | 203.95M | 96.81M | 70.13M | 44.82M | 30.35M | 11.50M |
| Operating Income Ratio | 43.09% | 30.83% | 30.53% | 29.94% | 30.63% | 32.18% | 32.67% | 28.02% | 22.66% | 21.13% | 19.29% | 16.06% | 9.03% | 9.00% | 7.38% | 5.13% | 1.86% |
| Total Other Income/Expenses | -1.58B | -1.37B | -1.38B | 202.89M | -531.75M | 181.29M | 119.90M | 89.99M | 101.36M | 1.21M | -53.25M | -12.73M | 14.91M | 12.12M | -8.34M | 1.35M | 1.64M |
| Income Before Tax | 5.64B | 4.51B | 3.86B | 3.14B | 2.69B | 2.27B | 1.88B | 1.22B | 800.25M | 533.89M | 356.91M | 221.40M | 111.72M | 82.25M | 36.48M | 32.08M | 13.14M |
| Income Before Tax Ratio | 33.66% | 30.77% | 30.55% | 29.92% | 31.22% | 34.97% | 34.90% | 30.32% | 25.94% | 21.21% | 20.62% | 17.43% | 10.42% | 10.56% | 6.01% | 5.43% | 2.12% |
| Income Tax Expense | 1.03B | 743.60M | 773.70M | 621.88M | 543.79M | 503.21M | 437.43M | 257.33M | 190.44M | 122.62M | 97.58M | 81.19M | 31.43M | 19.13M | 3.17M | 9.82M | 2.79M |
| Net Income | 4.57B | 3.76B | 3.00B | 2.42B | 2.15B | 1.77B | 1.45B | 961.59M | 609.75M | 410.37M | 258.49M | 139.84M | 80.07M | 62.82M | 33.32M | 22.26M | 10.35M |
| Net Income Ratio | 27.26% | 25.65% | 23.74% | 23.11% | 24.91% | 27.22% | 26.82% | 23.94% | 19.77% | 16.30% | 14.93% | 11.01% | 7.47% | 8.06% | 5.49% | 3.76% | 1.67% |
| EPS | 59.90 | 49.62 | 39.61 | 32.03 | 28.42 | 23.35 | 19.06 | 12.65 | 8.07 | 5.43 | 3.42 | 1.85 | 1.06 | 0.83 | 0.44 | 0.29 | 0.16 |
| EPS Diluted | 59.90 | 49.18 | 39.26 | 31.71 | 28.20 | 23.23 | 19.06 | 12.65 | 8.07 | 5.43 | 3.42 | 1.85 | 1.06 | 0.83 | 0.44 | 0.29 | 0.14 |
| Weighted Avg Shares Out | 76.31M | 75.83M | 75.70M | 75.64M | 75.64M | 75.61M | 75.58M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M |
| Weighted Avg Shares Out (Dil) | 76.31M | 76.51M | 76.37M | 76.32M | 76.23M | 75.99M | 75.96M | 75.61M | 75.56M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M | 75.55M |
Source: https://incomestatements.info
Category: Stock Reports